Kalamazoo Firm Presents Clinical Trial Results Of Alzheimer's DrugMetabolic Solutions Development Co. LLC announced that Jerry Colca, co-founder and chief scientific officer of MSDC, presented results of a Phase 2a study at the 14th International Conference on Alzheimer's Drug Discovery.
Metabolic Solutions To Present On Alzheimer's DrugMetabolic Solutions Development Co. LLC will provide an update on the clinical evaluation of MSDC-0160, a compound being investigated in an ongoing Phase 2a trial in subjects with mild to moderate dementia due to Alzheimer's disease, at the Alzheimer's Drug Discovery Foundation 13th International Conference on Alzheimer's Drug Discovery in Jersey City, N.J. Sept. 10.
Kalamazoo Pharma Gets Foundation Grant For Trial Of Alzheimer's DrugKalamazoo-based Metabolic Solutions Development Co. said Wednesday that it has received a $773,000 grant from the Alzheimer's Drug Discovery Foundation to conduct a pilot Phase 2a trial of MSDC-0160, MSDC's pioneer compound for the treatment of metabolic diseases associated with altered mitochondrial function.
Adeona Loss Drops On Revenue JumpThe Ann Arbor-based pharma startup Adeona Pharmaceuticals Inc. (Amex: AEN) reported a lower loss on sharply higher revenue for 2010 over 2009.

More From CBS Detroit

Best Christmas Light Displays
Best Holiday Drink Ideas
Top Hidden Destinations

Watch & Listen